questionsmedicales.fr
Actions chimiques et utilisations
Actions pharmacologiques
Utilisations thérapeutiques
Agents hématologiques
Coagulants
Hémostatiques
Hémostatiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Troubles de la coagulation
Tests de coagulation
Tests de coagulation
Hémostatiques
Saignement post-opératoire
Chirurgie
Antécédents médicaux
Anticoagulants
Symptômes
5
Hémorragie interne
Douleur abdominale
Troubles de la coagulation
Saignement
Réaction allergique
Hémostatiques
Prévention
5
Prévention des saignements
Interventions chirurgicales
Anticoagulants
Hygiène dentaire
Anticoagulants
Surveillance médicale
Hémophilie
Prévention des blessures
Éducation des patients
Hémostatiques
Traitements
5
Acide tranexamique
Vitamine K
Administration de médicaments
Hémostatiques
Saignement post-opératoire
Hémostatiques
Agents hémostatiques
Chirurgie
Effets secondaires
Hémostatiques
Complications
5
Réaction allergique
Antihistaminiques
Prévention des complications
Suivi médical
Signes d'alerte
Complications
Facteurs de risque
5
Facteurs de risque
Anticoagulants
Âge
Troubles de la coagulation
Médicaments
Anticoagulants
Maladies hépatiques
Coagulation
Comportements à risque
Alcool
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hémostatiques : Questions médicales les plus fréquentes",
"headline": "Hémostatiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hémostatiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-08",
"dateModified": "2025-04-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hémostatiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Coagulants",
"url": "https://questionsmedicales.fr/mesh/D003029",
"about": {
"@type": "MedicalCondition",
"name": "Coagulants",
"code": {
"@type": "MedicalCode",
"code": "D003029",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.502.270"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Agents d'inversion des anticoagulants",
"alternateName": "Anticoagulant Reversal Agents",
"url": "https://questionsmedicales.fr/mesh/D000089964",
"about": {
"@type": "MedicalCondition",
"name": "Agents d'inversion des anticoagulants",
"code": {
"@type": "MedicalCode",
"code": "D000089964",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.502.270.463.046"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antifibrinolytiques",
"alternateName": "Antifibrinolytic Agents",
"url": "https://questionsmedicales.fr/mesh/D000933",
"about": {
"@type": "MedicalCondition",
"name": "Antifibrinolytiques",
"code": {
"@type": "MedicalCode",
"code": "D000933",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.502.270.463.091"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hémostatiques",
"alternateName": "Hemostatics",
"code": {
"@type": "MedicalCode",
"code": "D006490",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Patricia Davenport",
"url": "https://questionsmedicales.fr/author/Patricia%20Davenport",
"affiliation": {
"@type": "Organization",
"name": "Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States."
}
},
{
"@type": "Person",
"name": "Martha Sola-Visner",
"url": "https://questionsmedicales.fr/author/Martha%20Sola-Visner",
"affiliation": {
"@type": "Organization",
"name": "Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States."
}
},
{
"@type": "Person",
"name": "Reihaneh Haghniaz",
"url": "https://questionsmedicales.fr/author/Reihaneh%20Haghniaz",
"affiliation": {
"@type": "Organization",
"name": "Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States."
}
},
{
"@type": "Person",
"name": "Ali Khademhosseini",
"url": "https://questionsmedicales.fr/author/Ali%20Khademhosseini",
"affiliation": {
"@type": "Organization",
"name": "Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States."
}
},
{
"@type": "Person",
"name": "A B Zemlyanoy",
"url": "https://questionsmedicales.fr/author/A%20B%20Zemlyanoy",
"affiliation": {
"@type": "Organization",
"name": "Pirogov National Medical and Surgical Center of Ministry of Health of Russia, Moscow, Russia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cognitive profile in functional disorders.",
"datePublished": "2023-11-30",
"url": "https://questionsmedicales.fr/article/37889124",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13546805.2023.2275336"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Uric acid, cognitive disorders, neurodegeneration].",
"datePublished": "2024-06-03",
"url": "https://questionsmedicales.fr/article/38829804",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.26442/00403660.2024.05.202698"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cognitive subgroups and their longitudinal trajectories in bipolar disorder.",
"datePublished": "2022-06-25",
"url": "https://questionsmedicales.fr/article/35690884",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/acps.13460"
}
},
{
"@type": "ScholarlyArticle",
"name": "An evolutionary account of impairment of self in cognitive disorders.",
"datePublished": "2022-09-30",
"url": "https://questionsmedicales.fr/article/36180662",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10339-022-01110-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cognitive impairment in bipolar disorder in comparison to mild cognitive impairment and dementia: a systematic review.",
"datePublished": "2023-02-20",
"url": "https://questionsmedicales.fr/article/34374270",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.47626/2237-6089-2021-0300"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Utilisations thérapeutiques",
"item": "https://questionsmedicales.fr/mesh/D045506"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agents hématologiques",
"item": "https://questionsmedicales.fr/mesh/D006401"
},
{
"@type": "ListItem",
"position": 6,
"name": "Coagulants",
"item": "https://questionsmedicales.fr/mesh/D003029"
},
{
"@type": "ListItem",
"position": 7,
"name": "Hémostatiques",
"item": "https://questionsmedicales.fr/mesh/D006490"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hémostatiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hémostatiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hémostatiques",
"description": "Comment diagnostiquer un trouble de la coagulation ?\nQuels signes indiquent un besoin d'hémostatiques ?\nQuels tests pour évaluer l'efficacité des hémostatiques ?\nComment évaluer un saignement post-opératoire ?\nQuels antécédents médicaux sont pertinents ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Cognition+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hémostatiques",
"description": "Quels sont les symptômes d'un saignement excessif ?\nComment reconnaître une hémorragie interne ?\nQuels signes d'alerte pour les troubles de la coagulation ?\nQuels symptômes d'une réaction aux hémostatiques ?\nComment identifier une thrombose ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Cognition+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hémostatiques",
"description": "Comment prévenir les saignements chez les patients à risque ?\nQuels conseils pour éviter les saignements ?\nComment surveiller les patients sous anticoagulants ?\nQuelles mesures pour les patients hémophiles ?\nComment éduquer les patients sur les hémostatiques ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Cognition+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hémostatiques",
"description": "Quels sont les principaux hémostatiques utilisés ?\nComment administrer des hémostatiques ?\nQuels traitements pour les saignements post-opératoires ?\nQuand utiliser des agents hémostatiques locaux ?\nQuels sont les effets secondaires des hémostatiques ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Cognition+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hémostatiques",
"description": "Quelles complications peuvent survenir avec les hémostatiques ?\nComment gérer une réaction allergique aux hémostatiques ?\nQuels risques de thrombose avec des hémostatiques ?\nComment prévenir les complications liées aux hémostatiques ?\nQuels signes d'alerte pour des complications ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Cognition+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hémostatiques",
"description": "Quels facteurs augmentent le risque de saignement ?\nComment l'âge influence-t-il le risque de saignement ?\nQuels médicaments augmentent le risque de saignement ?\nComment les maladies hépatiques affectent-elles la coagulation ?\nQuels comportements augmentent le risque de saignement ?",
"url": "https://questionsmedicales.fr/mesh/D006490?mesh_terms=Cognition+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un trouble de la coagulation ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins comme le temps de prothrombine et le temps de saignement sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un besoin d'hémostatiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements excessifs, des ecchymoses fréquentes ou des saignements prolongés peuvent indiquer un besoin."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'efficacité des hémostatiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des tests comme le temps de thrombine et le temps de céphaline activé."
}
},
{
"@type": "Question",
"name": "Comment évaluer un saignement post-opératoire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "On examine la quantité de sang perdu et la durée du saignement après la chirurgie."
}
},
{
"@type": "Question",
"name": "Quels antécédents médicaux sont pertinents ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de troubles de la coagulation ou d'utilisation d'anticoagulants sont importants."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'un saignement excessif ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des ecchymoses, des saignements de nez fréquents et des gencives qui saignent."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hémorragie interne ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs abdominales, des vertiges ou une pâleur peuvent indiquer une hémorragie interne."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte pour les troubles de la coagulation ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements prolongés après une coupure ou des saignements inhabituels sont des signes d'alerte."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une réaction aux hémostatiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, des démangeaisons ou des difficultés respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment identifier une thrombose ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un gonflement, une douleur ou une rougeur dans une jambe peuvent indiquer une thrombose."
}
},
{
"@type": "Question",
"name": "Comment prévenir les saignements chez les patients à risque ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "On peut prescrire des hémostatiques préventifs avant des interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Quels conseils pour éviter les saignements ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les anticoagulants non prescrits et maintenir une bonne hygiène dentaire."
}
},
{
"@type": "Question",
"name": "Comment surveiller les patients sous anticoagulants ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des contrôles réguliers de la coagulation sanguine sont nécessaires pour ajuster le traitement."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour les patients hémophiles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients hémophiles doivent éviter les sports de contact et suivre un traitement préventif."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur les hémostatiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer sur l'utilisation correcte, les effets secondaires et l'importance du suivi médical."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux hémostatiques utilisés ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les hémostatiques courants incluent l'acide tranexamique et la vitamine K."
}
},
{
"@type": "Question",
"name": "Comment administrer des hémostatiques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être administrés par voie orale, intraveineuse ou topique selon le type."
}
},
{
"@type": "Question",
"name": "Quels traitements pour les saignements post-opératoires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "On peut utiliser des compresses, des sutures ou des hémostatiques pour contrôler le saignement."
}
},
{
"@type": "Question",
"name": "Quand utiliser des agents hémostatiques locaux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés lors de chirurgies pour contrôler les saignements au site opératoire."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des hémostatiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des réactions allergiques, des nausées ou des thromboses."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les hémostatiques ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des thromboses, des réactions allergiques ou des troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Comment gérer une réaction allergique aux hémostatiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il faut arrêter le traitement et administrer des antihistaminiques ou des corticostéroïdes si nécessaire."
}
},
{
"@type": "Question",
"name": "Quels risques de thrombose avec des hémostatiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation excessive d'hémostatiques peut augmenter le risque de thrombose veineuse profonde."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux hémostatiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un ajustement des doses peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte pour des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques, des essoufflements ou des gonflements doivent alerter immédiatement."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de saignement ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, l'utilisation d'anticoagulants et certaines maladies augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il le risque de saignement ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées ont un risque accru de troubles de la coagulation et de saignements."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le risque de saignement ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants, les anti-inflammatoires non stéroïdiens et certains antibiotiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Comment les maladies hépatiques affectent-elles la coagulation ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maladies hépatiques peuvent altérer la production de facteurs de coagulation, augmentant le risque de saignement."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque de saignement ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "La consommation excessive d'alcool et le tabagisme peuvent augmenter le risque de saignement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States.
Publications dans "Hémostatiques" :
2 publications dans cette catégorie
Affiliations :
Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States.
Publications dans "Hémostatiques" :
2 publications dans cette catégorie
Affiliations :
Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States.
Publications dans "Hémostatiques" :
2 publications dans cette catégorie
Affiliations :
Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, United States.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Pirogov National Medical and Surgical Center of Ministry of Health of Russia, Moscow, Russia.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan. nnhk110184@kpe.biglobe.ne.jp.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Toyokawa City Hospital, 23 Nozi Yawata-cho, Toyokawa City, Aichi, 442-8561, Japan.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
96702State Key Laboratory of NBC Protection for Civilian, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, 96702Beijing Institute of Radiation Medicine, Beijing, PR China.
Publications dans "Hémostatiques" :
1 publication dans cette catégorie
Affiliations :
96702State Key Laboratory of NBC Protection for Civilian, Beijing, PR China.
Publications dans "Hémostatiques" :
Patients with functional disorders (FD) often experience cognitive problems such as forgetfulness and distractibility alongside physical symptoms that cannot be attributed to a known somatic disease....
Test scores of cognitive tests and psychiatric rating scales of 100 outpatients diagnosed with a functional disorder were compared to a control group (n = 300) of patients with other diagnoses and to ...
Out of the 100 patients with functional disorders, 59 reported significant subjective cognitive symptoms. A moderate difference (d = 0.5-0.7) was found between the FD group mean and the population mea...
The findings of the study suggest that a decline in processing speed is a central feature in the cognitive profile of patients with functional disorders....
This article examines the role of uric acid (UA) in cognitive changes and neurodegeneration, focusing on its functions as an antioxidant and prooxidant. Research suggests that changes in serum UA leve...
Cognitive functioning in bipolar disorder is heterogeneous with evidence for multiple subgroups. However, cognitive subgroup change patterns over time remains unknown. While prior work suggests minima...
Participants diagnosed with bipolar disorder (I, II, NOS; n = 568) and unaffected controls (n = 234) completed baseline, one- and five-year neuropsychological assessments. Data reduction techniques we...
Results were consistent with bipolar disorder participants forming three subgroups with high (n = 209), mid (n = 259), and low (n = 100) cognition. These groups were associated with unique clinical ch...
These results demonstrate that cognition-based subgroups of bipolar disorder participants have minimal differences in their longitudinal course in relation to each other and with unaffected controls....
Recent research has proposed that certain aspects of psychosis, as experienced in, e.g., schizophrenia (SCZ), but also aspects of other cognitive conditions, such as autism spectrum disorders (ASD) an...
To conduct a systematic review to describe cognitive abilities in bipolar disorder (BD) in comparison to cognitive abilities in mild cognitive impairment (MCI) and dementia....
A literature search was performed with no year or language restrictions. The search yielded 1,461 articles, with 1,261 remaining after removal of duplicates, five of which were suitable for the system...
Analyses from our systematic review showed that euthymic individuals with BD present impairments in cognitive domains such as attention and executive functioning, motor skills, conceptual thinking, an...
Findings from our systematic review suggest that cognitive impairments in euthymic BD fall into a range between the impairments seen in MCI and those seen in dementia. More studies are needed to analy...
Cognitive deficits are prevalent in bipolar disorder even during the euthymic phase, having a negative impact on global functioning and quality of life. As such, more and more mental health profession...
The aim of this study was to assess the knowledge, attitudes and the rules of proceeding concerning primary health care (PHC) doctors in the field of screening diagnostics for cognitive disorders in e...
The study included 175 PHC doctors. A validated anonymous questionnaire was used. The survey was conducted using the PAPI (Paper and Pencil Interviews) and CAWI (Computer Assisted Web Interviews) meth...
The vast majority of the respondents (n=159; 91.4%) saw the advisability of screening for cognitive disorders in the age group >65 years of age, but only 53 subjects (30.29%) believed that these tests...
Polish GPs are aware of the necessity of screening for cognitive disorders in seniors. Currently, there are no mechanisms within primary health care system that would enable proper early screening for...
Functional cognitive disorders (FCDs) are a common cause of subjective and mild cognitive impairment. Isolated FCDs commonly present to the cognitive clinic, but examination of the nature of the sympt...
Cognitive impairment is a core feature of mood disorders and has been identified as an important treatment target. A better understanding of the factors contributing to cognitive impairment in mood di...
Studies in adult samples examining the relationship between objective cognitive function and reported childhood trauma in major depressive disorder and/or bipolar disorder (in-episode or euthymia) wer...
Seventeen studies met the criteria for inclusion (mood disorders N = 1723, healthy controls N = 797). Evidence for childhood trauma being related to poorer cognitive functioning was consistent across ...
Findings from this review suggest childhood trauma is associated with poorer cognitive functioning in people with mood disorders. Targeted interventions to improve cognition may be warranted for this ...
Extensive literature has explored the beneficial effects of music in age-related cognitive disorders (ACD), but limited knowledge exists regarding its impact on gene expression. We analyzed transcript...